SUBSEQUENT PATENTING OF DIFFERENT FORMS OF KNOWN MEDICAL SUBSTANCES IN RUSSIA MAY BE CURTAILED IN THE FUTURE

marketude Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova, Alisa Pestryakova

[x_icon type="tag"] Intellectual Property, Russia

INTELLIGENZA ARTIFICIALE, DOVE VA IL QUADRO GIURIDICO INTERNAZIONALE E I PASSI NECESSARI

marketude Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Society

[x_icon type="tag"] Intellectual Property, Data protection and Cybersecurity, IT&TMT, Society

COVID-19: FOCUS CORPORATE, COMMERCIAL AND DISPUTE RESOLUTION – Webinar, De Berti Jacchia and CCIR, January 21st, 2021

marketude Coronavirus, Coronavirus, Coronavirus, Coronavirus, Coronavirus, Coronavirus, Coronavirus, Coronavirus, Coronavirus, Coronavirus, Coronavirus, Corporate and Commercial, Corporate and Commercial, Corporate and Commercial, Igor Brazhevsky, Moscow, Oksana Oleneva

[x_icon type="map-marker"] Webinar, De Berti Jacchia and CCIR[br]
[x_icon type="calendar"] January 21st, 2021[br]
[x_icon type="user"] Armando Ambrosio, Igor Brazhevsky, Alisa Pestryakova, Oksana Oleneva

REPRODUCTION OF A TRADEMARK IN DICTIONARIES UNDER ITALIAN LAW. A NEWLY CODIFIED RIGHT, BUT ALSO A BURDEN, FOR TRADEMARK OWNERS

marketude Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications

[x_icon type="tag"] Intellectual Property, Litigation

VACCINI, SALUTE E DIRITTO CAMMINANO FIANCO A FIANCO

marketude Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences

[br]

CASO MONTELUKAST LA CORTE D’APPELLO DI ROMA LIQUIDA IL DANNO A MSD

marketude Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia

[x_icon type="tag"] Intellectual Property, Pharmaceuticals and Life Sciences

THE RUSSIAN TELECOMS AND IT AUTHORITY (ROZKOMNADZOR) AGREES TO UPLOAD INTO WIPO ALERT INFORMATION ABOUT COPYRIGHT INFRINGING WEBSITES

marketude Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief, Russian Brief

[x_icon type="tag"] Intellectual Property, Russia

DE BERTI JACCHIA VINCE IN CORTE D’APPELLO DI ROMA PER MERCK SHARP & DOHME (MSD

marketude

De Berti Jacchia, con un team composto dai partner Roberto A. Jacchia, Maria Cristina Franchini e Silvia Doria, ha assistito vittoriosamente dinanzi alla Corte d’Appello di Roma Merck Sharp & Dohme Italia e Merck Canada Inc. (MSD) in una causa che le vedeva contrapposte a Teva Italia Srl, ed alla sua controllante israeliana Teva Pharmaceuticals Ltd.